What is the Impact Factor of Current Molecular Pharmacology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Current Molecular Pharmacology is 7.20, ranking in quartile Q1 of Web of Science (SCIE).

Is Current Molecular Pharmacology indexed in Web of Science or Scopus?

Yes, Current Molecular Pharmacology is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.024 (Q1) and an H-index of 54.

Who publishes Current Molecular Pharmacology and what is the Article Processing Charge (APC)?

Current Molecular Pharmacology is published by Bentham. The estimated Article Processing Charge (APC) is approximately $3,140 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Current Molecular Pharmacology?

The official ISO-4 abbreviation of Current Molecular Pharmacology is "CURR. MOL. PHARMACOL". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #4,726Hybrid

Current Molecular Pharmacology

Abbreviation (ISO):CURR. MOL. PHARMACOL

•

Identifier (ISSN):1874-4672(Print)/1874-4702(Online)

•

Publisher:Bentham

Official Website Submission Portal Compare

Clarivate IF (2026)

7.2↑ +4.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Current Molecular Pharmacology

WoS Q1

Annual Impact Factor Metric

Current (2026):7.2

Scopus SJR & RankScopus Q1

1.024

#4,726

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

54 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

97articles/year

58.16% Gold OA•39.71% Original Research

Aims & Scope

Current Molecular Pharmacology aims to publish the latest developments in cellular and molecular pharmacology with a major emphasis on the mechanism of action of novel drugs under development, innovative pharmacological technologies, cell signaling, transduction pathway analysis, genomics, proteomics, and metabonomics applications to drug action. An additional focus will be the way in which normal biological function is illuminated by knowledge of the action of drugs at the cellular and molecular level. The journal publishes full-length/mini reviews, original research articles and thematic issues on molecular pharmacology. Current Molecular Pharmacology is an essential journal for every scientist who is involved in drug design and discovery, target identification, target validation, preclinical and clinical development of drugs therapeutically useful in human disease.

Topics Covered (Recognized by AI)

Biology93.8%Medicine90.9%Chemistry82.7%Internal medicine81.1%Genetics80.2%Biochemistry79.6%Endocrinology41.7%Gene38.3%Cell biology36.8%Pharmacology35.7%Psychology34.5%Organic chemistry34.2%Pathology32.6%Physics27.6%Receptor27.3%Immunology26.6%Cancer research24.2%Cancer22%Neuroscience21.9%Psychiatry20.2%

Primary Research Areas

Pharmacology Toxicology and Pharmaceutics Drug Discovery

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Rank46/328

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank32/356

IndexSCIE

JCISCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Rank74/328

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank87/356

IndexSCIE

Category	Index	Rank	Quartile
BIOCHEMISTRY & MOLECULAR BIOLOGY	JCRSCIE	46/328	Q1
PHARMACOLOGY & PHARMACY	JCRSCIE	32/356	Q1
BIOCHEMISTRY & MOLECULAR BIOLOGY	JCISCIE	74/328	Q1
PHARMACOLOGY & PHARMACY	JCISCIE	87/356	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF7.2

Articles / Year27

Total Citations9

2025

IF2.9

Articles / Year40

Total Citations254

2024

IF2.4

Articles / Year48

Total Citations761

2023

IF2.7

Articles / Year57

Total Citations741

2022

IF3.855

Articles / Year87

Total Citations1,013

Year	Impact Factor	Articles / Year	Total Citations
2026	7.2	27	9
2025	2.9	40	254
2024	2.4	48	761
2023	2.7	57	741
2022	3.855	87	1,013
2021	3.339	103	1,435
2020	3.283	84	1,199
2019	1.596	42	1,111
2018	2.481	37	1,008
2017	—	34	887
2016	—	32	653
2015	—	66	1,702

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,726Scopus Q1SCImago Profile

Scopus Coverage:2008-2025

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

1.024

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

5.53

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,140 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,277

3-Year Documents257

Citable Documents249

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ1

PharmacologyQ1

Molecular MedicineQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Biology

Minor Category (Specific Field):

3区BIOCHEMISTRY & MOLECULAR BIOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Current Molecular Pharmacology (abbr: CURR. MOL. PHARMACOL, ISSN: 1874-4672) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Bentham in United Arab Emirates. The periodical holds a Journal Impact Factor (JIF) of 7.20, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.024 (Q1), an H-index of 54.

The journal enforces rigorous peer evaluation with an annual output of approximately 97 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,140 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.